- Home
- INDV vs OCUL Comparison
INDV vs OCUL Comparison
Compare INDV & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | OCUL |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.4B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | INDV | OCUL |
|---|---|---|
| Price | $35.82 | $12.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $32.50 | $22.56 |
| AVG Volume (30 Days) | 3.4M | ★ 4.1M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.98 | N/A |
| Revenue | ★ $1,180,000,000.00 | $55,783,000.00 |
| Revenue This Year | $1.09 | N/A |
| Revenue Next Year | N/A | $14.88 |
| P/E Ratio | $35.88 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.62 | $5.79 |
| 52 Week High | $38.00 | $16.44 |
Technical Indicators
Market Signals| Indicator | INDV | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 66.28 | 45.98 |
| Support Level | $34.91 | $11.15 |
| Resistance Level | $36.18 | $14.64 |
| Average True Range (ATR) | 0.92 | 0.90 |
| MACD | -0.20 | -0.15 |
| Stochastic Oscillator | 48.00 | 26.44 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.